Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C. Fabron
Prs49 - Cost-Effectiveness of the Fixed-Dose Combination Tiotropium + Olodaterol Versus Tiotropium Based on the Dynagito Trial Results in France
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Testing NISP Instrument on Ground
Related publications
P250 Effects of 12 Weeks of Once-Daily Tiotropium and Olodaterol Fixed-Dose Combination on Exercise Endurance in Patients With Copd
Thorax
Pulmonary
Respiratory Medicine
The Cost Effectiveness Analysis of Indacaterol Versus Tiotropium in a Chinese Medical Cost Setting
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Impact of Tiotropium + Olodaterol on Physical Functioning in COPD: Results of an Open-Label Observational Study
International Journal of COPD
Environmental
Public Health
Health Policy
Medicine
Pulmonary
Respiratory Medicine
Occupational Health
Tiotropium + Olodaterol Shows Clinically Meaningful Improvements in Quality of Life
Respiratory Medicine
Pulmonary
Respiratory Medicine
Characteristics of Patients With and Without COPD Exacerbations During the Tiotropium + Olodaterol TONADO Studies
Chest
Cardiology
Critical Care
Cardiovascular Medicine
Intensive Care Medicine
Pulmonary
Respiratory Medicine
Comment on Tiotropium
Respiratory Medicine
Pulmonary
Respiratory Medicine
Cost-Effectiveness of Tiotropium Versus Glycopyrronium in Moderate to Very Severe Chronic Obstructive Pulmonary Disease in Canada, Spain, Sweden, and the UK
ClinicoEconomics and Outcomes Research
Health Policy
Economics
Econometrics
Finance
Cost-Effectiveness of Aclidinium Bromide Compared With Tiotropium Bromide From the Perspective of Copd Patient Populations
International Journal of Medicine and Pharmacy
The Anti-Inflammatory Properties of Tiotropium
Lancet Respiratory Medicine,The
Pulmonary
Respiratory Medicine
